180 Tablets-label.jpg (180 Tablets Label)
Rivaroxaban Tablet, Film Coated
Product Images NDC 76282-774
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Rivaroxaban (NDC 76282-774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Exelan Pharmaceuticals,inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig_10.jpg (Fig 10)
Fig_11.jpg (Fig 11)
This text provides data on the cumulative incidence rate (%) over time for subjects randomized to receive a placebo in a study. The number of subjects at different time points is also mentioned.*
Fig_12.jpg (Fig 12)
Fig_2.jpg (Fig 2)
This text provides information on the population description related to end-stage renal disease, renal impairment, age, body weight, and hepatic impairment along with fold change and 90% confidence intervals. It includes categories such as normal, severe, moderate, and impairment levels for various health conditions and parameters.*
Fig_3.jpg (Fig 3)
Fig_9.jpg (Fig 9)
This is a study comparing the cumulative incidence rate (%) and hazard ratio (95% CI) between Apixaban and Placebo over 180 days from randomization. The number of subjects at risk in each group is also provided at intervals. Apixaban had 8313 subjects at the beginning compared to Placebo with 8261 subjects. Detailed data includes the subjects at risk over specific time points, supporting the analysis of the treatment's impact.*
Rivaroxaban Structure.jpg (Rivaroxaban Structure)
Label_60 Tablets.jpg (Label 60 Tablets)
The text provides important information about a medication called Tvaroxaban. Each tablet contains 2.5 mg of the active ingredient. It includes guidelines on dosage, storage at room temperature, excursions permitted, and keeping the medication out of children's reach. Manufacturer details are also disclosed, with Exelan Pharmaceuticals, Inc. based in Boca Raton, FL, and ScleGen Pharmaceuticals, Inc. in Hauppauge, NY. The text mentions the availability of a Medication Guide that should be dispensed to each patient.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
